As fears of a pandemic mount, the biotech company’s mRNA vaccine trial is set to release Phase 1/2 results later this year, with a larger Phase 3 trial expected to begin in 2025. 

Learn about your ad choices: <a href="https://dovetail.prx.org/ad-choices">dovetail.prx.org/ad-choices</a>

As fears of a pandemic mount, the biotech company’s mRNA vaccine trial is set to release Phase 1/2 results later this year, with a larger Phase 3 trial expected to begin in 2025. Learn about your ad choices: dovetail.prx.org/ad-choices

As fears of a pandemic mount, the biotech company’s mRNA vaccine trial is set to release Phase 1/2 results later this year, with a larger Phase 3 trial expected to begin in 2025. 

Learn about your ad choices: <a href="https://dovetail.prx.org/ad-choices" rel="noopener noreferrer">dovetail.prx.org/ad-choices</a>

US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine

Get in-depth coverage of current and future trends in technology, and how they are shaping business, entertainment, communications, science, politics, and society.

Business

Get in-depth coverage of current and future trends in technology, and how they are shaping business, entertainment, communications, science, politics, and society.

Share US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine

Sign up to save your podcasts

US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine

US Government Awards Moderna $176 Million for mRNA Bird Flu Vaccine

More shows like Business, Spoken

Uncanny Valley | WIRED

Science, Spoken

What's New

The Daily

Security, Spoken

Citadel Dropouts: a Game of Thrones Podcast